MRC Laboratory for Molecular Cell Biology, University College London, London WC1E 6BT, UK.
Institute of Microbiology and Infection, University of Birmingham, Birmingham B15 2TT, UK.
Viruses. 2022 Feb 19;14(2):431. doi: 10.3390/v14020431.
Modulation of the host cell cycle is a common strategy used by viruses to create a pro-replicative environment. To facilitate viral genome replication, vaccinia virus (VACV) has been reported to alter cell cycle regulation and trigger the host cell DNA damage response. However, the cellular factors and viral effectors that mediate these changes remain unknown. Here, we set out to investigate the effect of VACV infection on cell proliferation and host cell cycle progression. Using a subset of VACV mutants, we characterise the stage of infection required for inhibition of cell proliferation and define the viral effectors required to dysregulate the host cell cycle. Consistent with previous studies, we show that VACV inhibits and subsequently shifts the host cell cycle. We demonstrate that these two phenomena are independent of one another, with viral early genes being responsible for cell cycle inhibition, and post-replicative viral gene(s) responsible for the cell cycle shift. Extending previous findings, we show that the viral kinase F10 is required to activate the DNA damage checkpoint and that the viral B1 kinase and/or B12 pseudokinase mediate degradation of checkpoint effectors p53 and p21 during infection. We conclude that VACV modulates host cell proliferation and host cell cycle progression through temporal expression of multiple VACV effector proteins. (209/200.).
病毒通常采用调控宿主细胞周期的策略来创造有利于自身复制的环境。为促进病毒基因组复制,研究发现牛痘病毒(VACV)能够改变细胞周期调控并触发宿主细胞 DNA 损伤反应。然而,介导这些变化的细胞因子和病毒效应因子仍不清楚。在这里,我们着手研究 VACV 感染对细胞增殖和宿主细胞周期进程的影响。利用 VACV 突变体的一个子集,我们描述了感染的哪个阶段会抑制细胞增殖,并确定了扰乱宿主细胞周期所需的病毒效应因子。与之前的研究一致,我们表明 VACV 会抑制并随后改变宿主细胞周期。我们证明这两个现象是相互独立的,病毒早期基因负责细胞周期抑制,而复制后病毒基因(s)负责细胞周期转变。扩展先前的研究结果,我们表明病毒激酶 F10 被需要来激活 DNA 损伤检查点,并且病毒 B1 激酶和/或 B12 假激酶在感染过程中介导检查点效应物 p53 和 p21 的降解。我们得出结论,VACV 通过多个 VACV 效应蛋白的时间表达来调节宿主细胞增殖和宿主细胞周期进程。(209/200.)。